Back to Results

Lifevantage Corporation (LFVN)

LifeVantage Corporation is a consumer staples company focused on the identification, development, formulation, and sale of nutrigenomic activators and related health and personal care products. Its portfolio includes dietary supplements, nootropics, weight management products, prebiotics and probiotics, and skin and hair care items. The company’s offerings include Protandim, LifeVantage Omega+, ProBio, IC Bright, Daily Wellness, Rise AM and Reset PM System, D3+, PhysIQ Fat Burn, PhysIQ Prebiotic, MindBody GLP-1 System, Petandim for Dogs, and Axio, along with the TrueScience line of skin and hair care products. LifeVantage sells through its website and a network of independent consultants. The company is based in Lehi, Utah, and its common stock is listed on NASDAQ under the symbol LFVN.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-LFVN
$7.45
17.4% Upside
Fair
$7.50
18.1% Upside
Undervalued
Good
3.2%
November 4, 2026
15.3x
2.3x
0.4x
79.423 M
72.74 M
11.3%
69.8%
3.0
46.2%
131.5%
Valuation • Fair Value

Lifevantage Corporation (NASDAQ-LFVN) Fair Value by Valuation Model

Review the available estimates for Lifevantage Corporation (NASDAQ-LFVN), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$7.45

Estimated upside of 17.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$11.78

Discounted cash flow valuation reference.

Ben Graham Formula Value

$4.49

Classic Ben Graham valuation formula reference.

DDM Fair Value

$3.46

Dividend discount model valuation reference.

Comps Fair Value

$6.68

Comparable-company valuation reference.

Analyst Price Target

$7.50

Analysts imply upside of 18.1%.

How to read these valuation models

Use the 7 available valuation references for Lifevantage Corporation (NASDAQ-LFVN) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Lifevantage Corporation (NASDAQ-LFVN)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

182.6 M

Current operating scale indicator.

Revenue Forecast

163.9 M

Forward revenue estimate.

EBITDA

9.473 M

Current operating profitability reference.

EBITDA Forecast

10.399 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Lifevantage Corporation (NASDAQ-LFVN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Lifevantage Corporation (NASDAQ-LFVN)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.59

No elevated caution signal from this screen.

Altman Z-Score

3.0

Intermediate risk zone.

FCF / Net Income

131.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Lifevantage Corporation (NASDAQ-LFVN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Lifevantage Corporation (NASDAQ-LFVN)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 4, 2026

Days to Earnings

47

Dividend Yield

3.2%

Current income yield reference.

Payout Ratio

46.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Lifevantage Corporation (NASDAQ-LFVN), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Lifevantage Corporation (NASDAQ-LFVN) Stock Forecast & Technical Outlook

Review Lifevantage Corporation (NASDAQ-LFVN) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Lifevantage Corporation (NASDAQ-LFVN) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Lifevantage Corporation (NASDAQ-LFVN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Lifevantage Corporation (NASDAQ-LFVN) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Lifevantage Corporation (NASDAQ-LFVN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Lifevantage Corporation (NASDAQ-LFVN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Lifevantage Corporation (NASDAQ-LFVN)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Lifevantage Corporation (NASDAQ-LFVN) has a Buy consensus, with 1 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 1
Sell 0
FAQ • Fast Investor Answers

Lifevantage Corporation (NASDAQ-LFVN) Stock FAQ

Data-supported answers about Lifevantage Corporation (NASDAQ-LFVN), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$7.45
Estimated upside 17.4%
Valuation Rating
Undervalued
Estimated upside of 17.4%
Analyst Target
$7.50
Implied upside 18.1%
Financial Health
Good
Current financial-health read

The current fair value estimate for Lifevantage Corporation (NASDAQ-LFVN) is $7.45. This implies an estimated upside of 17.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 17.4% versus the current market price.

The available analyst price target for Lifevantage Corporation (NASDAQ-LFVN) is $7.50. The analyst target implies estimated upside of 18.1%.

The current financial health read for Lifevantage Corporation (NASDAQ-LFVN) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Lifevantage Corporation (NASDAQ-LFVN) is November 4, 2026.

Based on the current data, dividend yield is 3.2%.

The current P/E ratio listed for Lifevantage Corporation (NASDAQ-LFVN) is 15.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Lifevantage Corporation is 79.423 M.

The current enterprise value listed for Lifevantage Corporation is 72.74 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Lifevantage Corporation is NASDAQ-LFVN, and the stock is listed on NASDAQ.

Lifevantage Corporation (NASDAQ-LFVN) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Lifevantage Corporation is 11.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Lifevantage Corporation is 69.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Personal Care Products Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

UL NYSE Unilever PLC ADR Fair Value Fair Market Cap 133.3 B
KVUE NYSE Kenvue Inc Fair Value Fair Market Cap 34.209 B
EL NYSE Estee Lauder Companies Inc Fair Value Fair Market Cap 33.803 B
ELF NYSE ELF Beauty Inc Fair Value Fair Market Cap 5.691 B
IPAR NASDAQ Inter Parfums Inc Fair Value Fair Market Cap 3.603 B
COTY NYSE Coty Inc Fair Value Undervalued Market Cap 2.14 B
EPC NYSE Edgewell Personal Care Co Fair Value Undervalued Market Cap 1.253 B
HLF NYSE Herbalife Nutrition Ltd Fair Value Fair Market Cap 1.246 B
BRBR NYSE Bellring Brands LLC Fair Value Bargain Market Cap 1.044 B
ODD NASDAQ Oddity Tech Ltd Fair Value Undervalued Market Cap 834.2 M
HNST NASDAQ Honest Company Inc Fair Value Overvalued Market Cap 571.8 M
USNA NYSE USANA Health Sciences Inc Fair Value Bargain Market Cap 261.3 M
NAGE NASDAQ Niagen Bioscience Inc Fair Value Undervalued Market Cap 236.7 M
YSG NYSE Yatsen Holding Fair Value Undervalued Market Cap 233.6 M
NATR NASDAQ Natures Sunshine Products Inc Fair Value Undervalued Market Cap 229.1 M
NUS NYSE Nu Skin Enterprises Inc Fair Value Bargain Market Cap 222.9 M
MED NYSE MEDIFAST INC Fair Value Undervalued Market Cap 121.7 M
SKIN NASDAQ Skinhealth Systems Inc Fair Value Undervalued Market Cap 87.845 M
FTLF NASDAQ FitLife Brands Inc Fair Value Undervalued Market Cap 87.525 M
UPXI NASDAQ Upexi Inc Fair Value Fair Market Cap 83.612 M